BRAF and thyroid cancer, nonmedullary, 2: The prevalence of PTC/PTMC in the BRAF-like group reached 100% in 426 tumors, while 22 malignant nodules in the RAS-like group were composed of 14 PTC/PTMC (63.64%) and eight FTC or follicular patterned tumors (follicular variant PTC/PTMC, FV-PTC/FV-PTMC) (36.36%).